Alexandra Yakusheva: ThrombInnov Debuts at ISTH 2026 with a Focus on Translational Research
Alexandra Yakusheva, Preclinical Scientist at EFS, shared a post on LinkedIn:
“Excited to share something I’ve been working on over the past months.
Together with an amazing team, we have founded ThrombInnov, a CRO dedicated to thrombosis and haemostasis research, with the goal of making advanced preclinical models more accessible to academia and industry.
I’m proud to be one of the co-founders of this project and excited to contribute to building it from the ground up.
Today is also the first day of ISTH 2026, where Pierre Mangin and I will be representing ThrombInnov.
If you’re attending the congress and would like to discuss preclinical thrombosis models, collaborations or simply say hello, we’d be delighted to meet you.”
Stay updated with Hemostasis Today.
-
Aug 31, 2026, 05:19Tania Ahuja: Apixaban in Abdominal Transplant Patients
-
Aug 31, 2026, 04:28Reza Hafidz Irawan։ Automated Antibody Titration With Erytra Eflexis
-
Aug 31, 2026, 04:17Safa Chenganath: Stenosis vs Thrombosis – Hemodialysis Vascular Access
-
Aug 30, 2026, 17:13J. Meireles-Brandao: Hypertension, Inflammation and Lipoprotein Disease
-
Aug 30, 2026, 17:10Hugh Nguyen: Leading the New Era of Blood Services Across Asia Pacific
-
Aug 30, 2026, 17:09Transforming Childhood Through Access to Hemophilia Treatment – World Federation of Hemophilia
-
Aug 30, 2026, 17:07Raj Bharath: Connecting Clinicians and Researchers to Advance Transfusion Medicine
-
Aug 30, 2026, 17:04Rana Al Hrout: Free FRCPath Haematology Part 1 Exam Preparation Session
-
Aug 30, 2026, 17:02David McGlasson: A 2020 Article Reaches 8,000 Reads